ARTICLE | Company News
Newron, Zambon Co. S.p.A sales and marketing update
July 13, 2015 7:00 AM UTC
Zambon launched Xadago safinamide in Germany to treat mid- to late-stage Parkinson’s disease (PD). Zambon has rights to Xadago in the territory from Newron. The alpha-aminoamide derivative acts as a ...